Q2 2023 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2023-08-14 · accession 0001856083-23-000003
$2.16B
Reported value
55
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $155.0M | 7.17% | 1,250,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $137.2M | 6.35% | 6,500,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $116.3M | 5.38% | 2,834,069 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $113.2M | 5.24% | 7,370,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $110.0M | 5.09% | 2,646,782 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $102.8M | 4.76% | 5,421,330 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $98.0M | 4.54% | 1,548,252 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $93.9M | 4.35% | 3,000,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $93.0M | 4.30% | 3,546,435 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $84.7M | 3.92% | 6,557,816 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $77.6M | 3.59% | 24,170,966 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $73.4M | 3.40% | 4,050,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $71.9M | 3.33% | 2,819,045 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $67.4M | 3.12% | 3,187,415 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $53.7M | 2.49% | 1,500,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $50.2M | 2.32% | 2,778,107 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $48.0M | 2.22% | 30,000,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $42.1M | 1.95% | 1,317,316 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $35.7M | 1.65% | 15,000,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $34.1M | 1.58% | 835,446 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $30.4M | 1.41% | 1,279,502 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $29.9M | 1.39% | 2,997,830 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $28.9M | 1.34% | 2,727,606 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $28.4M | 1.32% | 3,453,744 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $28.1M | 1.30% | 2,499,912 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $27.7M | 1.28% | 514,021 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $27.6M | 1.28% | 384,200 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $25.2M | 1.17% | 2,781,565 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $21.3M | 0.99% | 2,750,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $20.7M | 0.96% | 2,523,000 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $19.3M | 0.89% | 1,451,201 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $18.8M | 0.87% | 3,916,361 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $18.8M | 0.87% | 1,004,561 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $17.1M | 0.79% | 250,000 | PUT | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $16.7M | 0.77% | 1,773,409 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $14.1M | 0.65% | 1,697,415 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $13.9M | 0.64% | 7,720,688 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $12.4M | 0.58% | 216,752 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $10.7M | 0.50% | 1,951,580 | Common | SOLE |
| 68570P101 | — | ORCHARD THERAPEUTICS PLC | $10.6M | 0.49% | 2,041,670 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $10.3M | 0.48% | 17,973,464 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $9.6M | 0.45% | 1,099,192 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $9.5M | 0.44% | 503,100 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $9.2M | 0.42% | 1,644,021 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $8.5M | 0.39% | 300,300 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $7.0M | 0.32% | 2,837,818 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $5.9M | 0.27% | 499,400 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $5.6M | 0.26% | 678,360 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $5.5M | 0.26% | 108,450 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $3.2M | 0.15% | 1,022,892 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $2.4M | 0.11% | 2,086,704 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $2.1M | 0.10% | 764,700 | CALL | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $995,288 | 0.05% | 228,277 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $773,868 | 0.04% | 308,314 | Common | SOLE |
| 603693102 | — | MINK THERAPEUTICS INC | $682,221 | 0.03% | 324,867 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.